SCHEMBL9106739

SCHEMBL9106739

COc1ccc2c(c1)C(=O)C(=O)N2C(CC(C)C)C(=O)Nc1ccccn1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GCK P35557 2/20 0.44
ALDH1A1 P00352 4/20 0.43
RAB9A P51151 4/20 0.43
NPC1 O15118 3/20 0.43
F2 P00734 1/20 0.43
GRM5 P41594 1/20 0.42
MAPT P10636 3/20 0.41
LMNA P02545 2/20 0.41
SMN1; SMN2 Q16637 1/20 0.41
NPSR1 Q6W5P4 1/20 0.41
TP53 P04637 2/20 0.40
L3MBTL1 Q9Y468 1/20 0.40
MMP1 P03956 1/20 0.40
MMP2 P08253 1/20 0.40
MMP3 P08254 1/20 0.40
MMP7 P09237 1/20 0.40
MMP9 P14780 1/20 0.40
BRD4 O60885 1/20 0.40
MEN1 O00255 1/20 0.39
KMT2A Q03164 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9107525 0.89 CHRM5 (0.46) GCKALDH1A1RAB9ANPC1
SCHEMBL9105850 0.89 KDM4E (0.43) GCKRAB9ASMN1; SMN2MEN1KMT2A
SCHEMBL9908092 0.89 KDM4E (0.43) GCKRAB9ASMN1; SMN2MEN1KMT2A
SCHEMBL9108285 0.88 GCK (0.46) GCKALDH1A1RAB9ANPC1LMNA
SCHEMBL9103795 0.87 FFAR2 (0.46) GCKALDH1A1RAB9ANPC1MAPT
SCHEMBL9109212 0.87 GCK (0.46) GCKALDH1A1RAB9ANPC1LMNA
SCHEMBL9108958 0.86 GCK (0.53) GCKALDH1A1RAB9ANPC1LMNA
SCHEMBL9108287 0.85 GCK (0.55) GCKALDH1A1RAB9ANPC1F2
SCHEMBL9103283 0.84 F2 (0.42) GCKALDH1A1RAB9ANPC1F2
SCHEMBL9103462 0.83 GCK (0.62) GCKALDH1A1RAB9ANPC1LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20120142705-A1 ISATIN AND OXINDOLE COMPOUNDS KESTER ROBERT FRANCIS (US) 2012-06-07 US claimed
US-20120142705-A1 ISATIN AND OXINDOLE COMPOUNDS KESTER ROBERT FRANCIS (US) 2012-06-07 US disclosed
US-20120142705-A1 ISATIN AND OXINDOLE COMPOUNDS KESTER ROBERT FRANCIS (US) 2012-06-07 US disclosed
US-20120142705-A1 ISATIN AND OXINDOLE COMPOUNDS KESTER ROBERT FRANCIS (US) 2012-06-07 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120142705-A1 ISATIN AND OXINDOLE COMPOUNDS GPR119, INSR, OAT GCK 488/4885ALDH1A1 646/4885RAB9A 1778/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.